Healthcare Services

Adult Intraventricular Hemorrhage Market Global Report 2026 Market Forecast 2026–2035 Reflecting Expansion Opportunities Across Industries

March 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Adult Intraventricular Hemorrhage Market In 2026 And What Value Is Projected For 2030?

The adult intraventricular hemorrhage market size has experienced significant growth in recent years. It is projected to increase from $2.22 billion in 2025 to $2.35 billion in 2026, driven by a compound annual growth rate (CAGR) of 6.1%. The expansion observed in the historic period can be ascribed to the increasing incidence of stroke and brain trauma, rising awareness of neurological disorders, limited availability of advanced neurosurgical devices, adoption of conventional ivh management protocols, and growing hospital and specialty clinic infrastructure.

The adult intraventricular hemorrhage market size is projected to experience robust expansion in the coming years. It is expected to reach $2.9 billion in 2030, growing at a compound annual growth rate (CAGR) of 5.4%. This anticipated growth over the forecast period can be attributed to the development of minimally invasive surgical devices, the increasing utilization of smart monitoring technologies, the rising adoption of novel hemostatic and neuroprotective drugs, the expansion of IVH-focused clinical research, and the growing demand for homecare and ambulatory intervention solutions. Key trends during the forecast period include the increasing integration of external ventricular drainage (EVD) systems, a greater application of minimally invasive neurosurgical tools, an escalating demand for hemostatic and antihypertensive drugs, the proliferation of advanced intracranial monitoring devices, and a significant focus on rapid diagnosis and early intervention in IVH.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17051&type=smp

What Key Drivers Are Influencing The Growth Of The Adult Intraventricular Hemorrhage Market?

The rising number of stroke occurrences is projected to stimulate the expansion of the adult intraventricular hemorrhage market moving forward. A stroke is a critical medical event that arises when the blood supply to the brain is disrupted or lessened, leading to damage of brain cells. This growing frequency of strokes primarily stems from factors such as an aging population, increasing rates of hypertension, diabetes, and obesity, and lifestyle-related risks like smoking and physical inactivity. Strokes can induce adult intraventricular hemorrhage (IVH) by causing bleeding within the brain’s ventricular system, often due to the rupture of blood vessels. For instance, in October 2025, the Australian Institute of Health and Welfare, an Australia-based independent statutory government agency, documented approximately 41,100 stroke incidents in Australia in 2023, averaging around 113 cases daily. Thus, the escalating incidence of strokes is propelling the development of the adult intraventricular hemorrhage market.

What Are The Key Segments Of The Adult Intraventricular Hemorrhage Market?

The adult intraventricular hemorrhage market covered in this report is segmented –

1) By Product Type: Surgical Devices, Drugs, Monitoring Devices

2) By Distribution Channel: Direct Sales, Distributors, Online Platforms, Other Distribution Channels

3) By Application: Primary Intraventricular Hemorrhage, Secondary Intraventricular Hemorrhage, Post-Traumatic Intraventricular Hemorrhage, IVH with Hydrocephalus, Other Applications

4) By End-User: Hospitals, Specialty Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Surgical Devices: Craniotomy Instruments, External Ventricular Drainage (EVD) Systems, Surgical Clips And Staples, Endoscopic Tools

2) By Drugs: Hemostatic Agents, Antihypertensive Drugs, Sedatives And Analgesics

3) By Monitoring Devices: Intracranial Pressure (ICP) Monitors, Brain Oxygenation Monitors, Cerebral Blood Flow (CBF) Monitors, Neuroimaging Devices

What Key Trends Are Influencing The Development Of The Adult Intraventricular Hemorrhage Market?

Major companies operating in the adult intraventricular hemorrhage market are concentrating on creating innovative products, such as neuroaccess devices, for the neurovascular treatment of ischemic and hemorrhagic strokes. Neuroaccess devices are medical instruments employed to gain entry to the brain or spinal cord for diagnostic or therapeutic procedures. For instance, in June 2024, Penumbra Inc., a US-based medical device company, announced the CE Mark approval and European launch of its BMX81 and BMX96 neuroaccess devices for managing ischemic and hemorrhagic stroke. These devices are specifically designed for the neurovascular management of ischemic and hemorrhagic strokes and represent Penumbra’s most advanced neuroaccess offerings. Unlike traditional access catheters, the BMX81 and BMX96 incorporate laser-cut stainless steel hypo tube technology, providing stability and trackability to facilitate physicians’ easy navigation through the brain’s complex anatomy.

Who Are The Leading Companies Operating In The Adult Intraventricular Hemorrhage Market?

Major companies operating in the adult intraventricular hemorrhage market are Johnson and Johnson, Abbott Laboratories, Medtronic Plc, Siemens Healthineers, Medline Industries, Philips Healthcare Inc., Stryker Corporation, GE HealthCare Technologies Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Alcon Inc., Zimmer Biomet Holdings Inc., Olympus Corporation, Smith and Nephew, Kaneka Corporation, Karl Storz SE and Co. KG, Carl Zeiss Meditec AG, Integra Lifesciences Holdings Corp, Elekta AB, Leica Microsystems GmbH, KLS Martin Group, Natus Medical Incorporated, Aesculap Inc., NeuroPace Inc., Sophysa USA Inc, Spiegelberg GmbH and Co. KG, Vivonics Inc.

Read the full adult intraventricular hemorrhage market report here:

https://www.thebusinessresearchcompany.com/report/adult-intraventricular-hemorrhage-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Adult Intraventricular Hemorrhage Market?

North America was the largest region in the adult intraventricular hemorrhage market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adult intraventricular hemorrhage market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Adult Intraventricular Hemorrhage Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=17051&type=smp

Browse Through More Reports Similar to the Global Adult Intraventricular Hemorrhage Market 2026, By The Business Research Company

intracranial stents global market report

https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

intravascular catheters global market report

https://www.thebusinessresearchcompany.com/report/intravascular-catheters-global-market-report

vascular embolization global market report

https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795